Custom pyrosequencing assay to detect short BRAF deletions in Langerhans cell histiocytic lesions.

Abstract excerpt

Langerhans cell histiocytosis (LCH) is a rare inflammatory myeloid neoplastic disease driven by activating mutations in the mitogen-activating protein kinase signalling pathway, including the BRAF V600E mutation and BRAF deletions (BRAFdel). Next-generation sequencing and whole exome sequencing (WES) are valuable and powerful approaches for BRAFdel identification, but these techniques are costly and time...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biopsy
• Share to Gene Deletion